Drug Trial Radar · NCT06589986
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Sep 17, 2024
Primary completion
Jan 30, 2027
Study completion Jan 30, 2031
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- Collaborators
- Chugai Pharmaceutical
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).
Conditions
- Moderately to Severely Active Ulcerative Colitis
Interventions
AfimkibartDrug
Afimkibart will be administered as IV infusion. Afimkibart will be administered as SC injection.
PlaceboDrug
Placebo matching IV afimkibart. Placebo matching SC afimkibart.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with Clinical Remission at Week 12Time frame: At Week 12
- Percentage of Participants with Clinical Remission at Week 52Time frame: At Week 52
Locations
184 sites in 30 countries. Site status is shown where the registry gives one.
Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan
Dothan, Alabama
Om Research LLC
Lancaster, California
University of California Irvine
Orange, California
Peak Gastroenterology Associates
Colorado Springs, Colorado
Access Research Institute
Brooksville, Florida
Gastro Florida
Clearwater, Florida
Clinical Research of Osceola, LLC
Kissimmee, Florida
Auzmer Research
Lakeland, Florida
Florida Research Institute - Lakewood
Lakewood Rch, Florida
Homestead Associates in Research, Inc.
Miami, Florida
Allied Biomedical Research Institute, Inc
Miami, Florida
Miami Beach Clinical Research Center
Miami Beach, Florida
Theia Clinical Research Centers, LLC
Tampa, Florida
Florida Medical Clinic
Zephyrhills, Florida
Gastroenterology Associates of Central Georgia
Macon, Georgia
Grand Teton Research Group, PLLC
Idaho Falls, Idaho
The University of Chicago
Chicago, Illinois
Indiana University Health University Hospital
Indianapolis, Indiana
Gastroenterology Health Partners, PLLC
New Albany, Indiana
Tri-State Gastroenterology Associates
Crestview Hills, Kentucky
Gastroenterology Health Partners, PLLC
Louisville, Kentucky
Louisiana Research Center - GastroIntestinal Associates
Shreveport, Louisiana
Brigham & Womens Hosp
Boston, Massachusetts
Boston University
Boston, Massachusetts
Allied Gastrointestinal Associates, PA
Flowood, Mississippi
Intercity Gastroenterology
Fresh Meadows, New York
Pioneer Clinical Research NY
New York, New York
Digestive Health Partners, PA
Asheville, North Carolina
Peters Medical Research (PMR), LLC
High Point, North Carolina
Monroe Biomedical Research
Monroe, North Carolina
Cleveland Clinic Foundation
Cleveland, Ohio
Ohio Gastroenterology Group
Columbus, Ohio
Gastro Intestinal Research Institute of Northern Ohio
Westlake, Ohio
University Gastroenterology
Providence, Rhode Island
Medical University of South Carolina (MUSC)
Charleston, South Carolina
Gastro One
Cordova, Tennessee
Gastrointestinal Associates of Northeast Tennessee
Johnson City, Tennessee
The University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
GI Alliance
Garland, Texas
TDDC dba GI Alliance Research
Mansfield, Texas
Showing 40 of 184 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.